Cel-Sci
CVM
#9766
Rank
A$77.61 M
Marketcap
A$9.71
Share price
2.54%
Change (1 day)
-62.72%
Change (1 year)

Cel-Sci (CVM) - Cash on Hand

Cash on Hand as of June 2025 : A$2.69 Million

According to Cel-Sci 's latest financial reports the company has A$2.69 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Cel-Sci - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-09-30A$6.85 M6.23%
2023-09-30A$6.44 M-81.7%
2022-09-30A$35.24 M-39.62%
2021-09-30A$58.37 M169.74%
2020-09-30A$21.64 M73.06%
2019-09-30A$12.5 M-12.38%
2018-09-30A$14.27 M372.57%
2017-09-30A$3.02 M-20.95%
2016-09-30A$3.82 M-53.23%
2015-09-30A$8.16 M-16.16%
2014-09-30A$9.74 M21724.9%
2013-09-30A$0.04 M-98.83%
2012-09-30A$3.8 M-12.98%
2011-09-30A$4.37 M-84.12%
2010-09-30A$27.54 M-28.73%
2009-09-30A$38.65 M3260.31%
2008-09-30A$1.15 M-90.64%
2007-09-30A$12.29 M13.48%
2006-09-30A$10.83 M320.21%
2005-09-30A$2.57 M-56.66%
2004-09-30A$5.94 M130.2%
2003-09-30A$2.58 M-32.45%
2002-09-30A$3.82 M-20.87%
2001-09-30A$4.83 M-75.34%
2000-09-30A$19.6 M117%
1999-09-30A$9.03 M-57.15%
1998-09-30A$21.07 M336.64%
1997-09-30A$4.82 M9.13%
1996-09-30A$4.42 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Curis
CRIS
A$13.62 M 404.84%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
A$0.32 B 11,773.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$14.21 B 526,711.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A$0.70 B 26,173.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.31 B 122,776.30%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
A$27.94 B 1,035,229.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.36 B 13,593.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
A$4.58 M 69.95%๐Ÿ‡บ๐Ÿ‡ธ USA